Stay updated on Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry v3.6.4 was added to the study record history, reflecting an update to the record. The previous revision v3.6.3 is removed from the visible history.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe study record history now shows a new revision entry (v3.6.3) and removes the previous revision (v3.6.1), indicating an update to the page's version history.SummaryDifference0.1%

- Check42 days agoChange DetectedThe study record history now includes a new revision entry (v3.6.1), updating the version history. This replaces the previous v3.6.0 entry.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry v3.5.5 was added to the history and the previous v3.5.4 entry was removed. This reflects an update to the page's revision record.SummaryDifference0.1%

- Check78 days agoChange DetectedThe Record History now includes a new revision entry, v3.5.4, replacing the previous v3.5.3. This reflects a small update to the page's revision metadata rather than any change to the study content.SummaryDifference0.1%

- Check100 days agoChange DetectedThe Record History now lists Revision: v3.5.3, replacing the previous Revision: v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.